Glucocorticoid receptor agonist dexamethasone attenuates renal ischemia/reperfusion injury by up-regulating eNOS/iNOS

Abstract

The aim of this study was to determine the effect of dexamethasone (DEX) on renal ischemia/reperfusion injury (IRI). C57BL/6 mice were randomly divided into Sham group, IRI group and DEX group. The mice in IRI and DEX groups subjected to renal ischemia for 60 min, were treated with saline or DEX (4 mg/kg, i.p.) 60 min prior to I/R. After 24 h of reperfusion, the renal function, renal pathological changes, activation of extracellular signal-regulated kinase (ERK) and glucocorticoid receptor (GR), and the levels of iNOS and eNOS were detected. The results showed DEX significantly decreased the damage to renal function and pathological changes after renal IRI. Pre-treatment with DEX reduced ERK activation and down-regulated the level of iNOS, whereas up-regulated the level of eNOS after renal IRI. DEX could further promote the activation of GR. These findings indicated GR activation confers preconditioning-like protection against acute IRI partially by up-regulating the ratio of eNOS/iNOS.

Keywords

ischemia/reperfusion injury / dexamethasone / nitric oxide synthase

References

[1] CarlDE, GrossmanC, BehnkeM, et al.. Effect of timing of dialysis on mortality in critically ill, septic patients with acute renal failure. Hemodial Int, 2010, 14(1): 11-17

[2] ZarjouA, AgarwalA. Sepsis and acute kidney injury. J Am Soc Nephrol, 2011, 22(6): 999-1006

[3] LeibowitzAB. Hypovolemia is not a common cause of acute kidney injury. Crit Care Med, 2010, 38(6): 1505-1506

[4] ChronopoulosA, RosnerMH, CruzDN, et al.. Acute kidney injury in the elderly: a review. Contrib Nephrol, 2010, 165: 315-321

[5] van den AkkerEK, ManintveldOC. Protection against renal ischemia-reperfusion injury by ischemic postconditioning. Transplantation, 2013, 95(11): 1299-1305

[6] van der VlietJA, WarleMC. The need to reduce cold ischemia time in kidney transplantation. Curr Opin Organ Transplant, 2013, 18(2): 174-178

[7] McQuarrieEP, FellstromBC, HoldaasH, et al.. Cardiovascular disease in renal transplant recipients. J Ren Care, 2013, 36(1): 136-145

[8] YapSC, LeeHT. Adenosine and protection from acute kidney injury. Curr Opin Nephrol Hypertens, 2012, 12(1): 24-32

[9] KimJI, JangHS, ParkKM. Endotoxin-induced renal tolerance against ischemia and reperfusion injury is removed by iNOS, but not eNOS, gene-deletion. BMB Rep, 2012, 43(9): 629-634

[10] KalyanaramanB. Teaching the basics of redox biology to medical and graduate students: Oxidants, antioxidants and disease mechanisms. Redox Biol, 2012, 1(1): 244-257

[11] SchneiderR, RaffU, VornbergerN, et al.. L-Arginine counteracts nitric oxide deficiency and improves the recovery phase of ischemic acute renal failure in rats. Kidney Int, 2003, 64(1): 216-225

[12] SchrammL, LaM, HeidbrederE, et al.. L-arginine deficiency and supplementation in experimental acute renal failure and in human kidney transplantation. Kidney Int, 2002, 61(4): 1423-1432

[13] ChenH, XingB, LiuX, et al.. Ozone oxidative preconditioning protects the rat kidney from reperfusion injury: the role of nitric oxide. J Surg Res, 2008, 149(2): 287-295

[14] UrnerM, HerrmannIK, BooyC, et al.. Effect of hypoxia and dexamethasone on inflammation and ion transporter function in pulmonary cells. Clin Exp Immunol, 2012, 169(2): 119-128

[15] DasA, SalloumFN, XiL, et al.. ERK phosphorylation mediates sildenafil-induced myocardial protection against ischemia-reperfusion injury in mice. Am J Physiol Heart Circ Physiol, 2009, 296(5): H1236-H1243

[16] BladhLG, Johansson-HaqueK, RafterI, et al.. Inhibition of extracellular signal-regulated kinase (ERK) signaling participates in repression of nuclear factor (NF)-kappaB activity by glucocorticoids. Biochim Biophys Acta, 2009, 1793(3): 439-446

[17] KumarS, AllenDA, KieswichJE, et al.. Dexamethasone ameliorates renal ischemia-reperfusion injury. J Am Soc Nephrol, 2009, 20(11): 2412-2425

[18] RouillardC, ChiodoLA, FreemanAS. The effects of the phencyclidine analogs BTCP and TCP on nigrostriatal dopamine neuronal activity. Eur J Pharmacol, 1990, 182(2): 227-235

[19] ZhengX, FengB, ChenG, et al.. Preventing renal ischemia-reperfusion injury using small interfering RNA by targeting complement 3 gene. Am J Transplant, 2006, 6(9): 2099-2108

[20] SchwartzD, MendoncaM, SchwartzI, et al.. Inhibition of constitutive nitric oxide synthase (NOS) by nitric oxide generated by inducible NOS after lipopolysaccharide administration provokes renal dysfunction in rats. J Clin Invest, 1997, 100(2): 439-448

[21] WessellsH, TealTH, LuttrellIP, et al.. Effect of endothelial cell-based iNOS gene transfer on cavernosal eNOS expression and mouse erectile responses. Int J Impot Res, 2003, 18(5): 438-445

[22] SampaioAL, DalliJ, BrancaleoneV, et al.. Biphasic modulation of NOS expression, protein and nitrite products by hydroxocobalamin underlies its protective effect in endotoxemic shock: downstream regulation of COX-2, IL-1beta, TNF-alpha, IL-6, and HMGB1 expression. Mediators Inflamm, 2013, 3(1): 791-804

[23] Sanchez-PozosK, BobadillaNA. Is aldosterone a modulator of vascular tone. Rev Invest Clin, 2013, 64(7): 546-557

[24] KielsteinA, TsikasD, GallowayGP, et al.. Asymmetric dimethylarginine (ADMA)—a modulator of nociception in opiate tolerance and addiction?. Nitric Oxide, 2007, 17(2): 55-59

[25] GoligorskyMS, BrodskySV, NoiriE. Nitric oxide in acute renal failure: NOS versus NOS. Kidney Int, 2002, 61(3): 855-861

[26] MatsumotoT, Kuriwaka-KidoR, KondoT, et al.. Regulation of osteoblast differentiation by interleukin-11 via AP-1 and Smad signaling. Endocr J, 2012, 59(2): 91-101